Skip to content

Clinical trials

Phase 1 Epilepsy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 1 Clear all

137 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20025
20031
20045
20058
20064
200711
20089
20093
20106
20117
20124
20136
20146
20154
20162
20173
20184
20193
20203
20215
20227
20233
20248
20258
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed100
Terminated10
Recruiting9
Not yet recruiting7
Unknown status7
Active, not recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bial - Portela C S.A.31
GlaxoSmithKline12
National Institute of Neurological Disorders and Stroke (NINDS)5
Eli Lilly and Company3
Mayo Clinic3
NeuroPro Therapeutics, Inc.3
UCB Biopharma SRL3
UCB Pharma3
University of Minnesota3
University of Texas Southwestern Medical Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy137
Seizures16
Drug Resistant Epilepsy7
Epilepsies, Partial3
Memory Disorders3
Alzheimer Disease2
Bipolar Disorder2
Brain Injuries, Traumatic2
Central Nervous System Diseases2
Cognitive Dysfunction2

Trials

Showing 76 to 100 of 137. Each trial links to its page on Pharma Observatory.

37 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.